AI assistant
Sending…
Processa Pharmaceuticals, Inc. — Director's Dealing 2025
Feb 18, 2025
35172_dirs_2025-02-18_acaf999d-4042-4cb3-a601-c369250d6c4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-02-17
Reporting Person: Lin Patrick (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-29 | Warrants | $0.65 | A | 43500 | Acquired | 2030-01-29 | Common Stock (43500) | Indirect |
| 2025-01-29 | Warrants | $0.65 | A | 21750 | Acquired | 2030-01-29 | Common Stock (21750) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 29059 | Direct |
| Common Stock | 43500 | Indirect |
More from Processa Pharmaceuticals, Inc.
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 7
Regulatory Filings
2025
Dec 15
Major Shareholding Notification
2025
Nov 7
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 15